MMUT
Basic information
Region (hg38): 6:49430360-49463253
Previous symbols: [ "MUT" ]
Links
Transcripts
Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 4 of 22.
| Transcript ID | Protein ID | Coding exons | MANE Select | MANE Plus Clinical |
|---|---|---|---|---|
ENST00000274813.4 | ENSP00000274813.3 | 12 | yes | - |
ENST00000878060.1 | ENSP00000548119.1 | 12 | - | - |
ENST00000878061.1 | ENSP00000548120.1 | 11 | - | - |
ENST00000878062.1 | ENSP00000548121.1 | 12 | - | - |
Phenotypes
GenCC
Source:
- methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (Definitive), mode of inheritance: AR
- methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (Strong), mode of inheritance: AR
- vitamin B12-unresponsive methylmalonic acidemia type mut- (Supportive), mode of inheritance: AR
- vitamin B12-unresponsive methylmalonic acidemia type mut0 (Supportive), mode of inheritance: AR
- methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Methylmalonic acidemia due to methylmalonyl-CoA mutase deficiency | AR | Biochemical | Long-term dietary (high-calorie diet low in propiogenic amino acid precursors with carnitine supplementation) and medical management (eg, IM hydroxocobalamin, antibiotics to decrease propionate production) is indicated; Fasting and high-protein consumption should be avoided; In the emergent setting, prompt recognition and appropriate metabolic care may be beneficial to decrease morbidity and mortality; Antioxidants for optic nerve atrophy may be beneficial; Liver/kidney transplant has been described in methylmalonic acidemia | Biochemical; Hematologic; Cardiovascular; Neurologic; Ophthalmologic | 6132336; 1977311; 1970180; 1968706; 1346616; 1351030; 7681251; 15643616; 12948746; 16451139; 18563634; 20301409; 22614770; 22695176 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (872 variants)
- Methylmalonic_aciduria_due_to_methylmalonyl-CoA_mutase_deficiency (351 variants)
- not_specified (151 variants)
- Methylmalonic_aciduria_due_to_complete_methylmalonyl-CoA_mutase_deficiency (145 variants)
- Methylmalonic_acidemia (82 variants)
- MMUT-related_disorder (25 variants)
- METHYLMALONIC_ACIDURIA,_mut(0)_TYPE (14 variants)
- Likely_inborn_error_of_metabolism (3 variants)
- Abnormality_of_metabolism/homeostasis (3 variants)
- METHYLMALONIC_ACIDURIA,_mut(-)_TYPE (3 variants)
- Methylmalonic_aciduria (2 variants)
- Neonatal_encephalopathy (1 variants)
- Peroxisome_biogenesis_disorder_8B (1 variants)
- Peroxisome_biogenesis_disorder_8A_(Zellweger) (1 variants)
- See_cases (1 variants)
- Acute_infantile_liver_failure_due_to_synthesis_defect_of_mtDNA-encoded_proteins (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MMUT gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000255.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | 237 | 3 | 248 | ||
| missense | 64 | 119 | 269 | 11 | 1 | 464 |
| nonsense | 56 | 26 | 82 | |||
| start loss | 1 | 1 | ||||
| frameshift | 73 | 28 | 3 | 104 | ||
| splice donor/acceptor (+/-2bp) | 20 | 22 | 5 | 47 | ||
| Total | 214 | 195 | 285 | 248 | 4 |
Highest pathogenic variant AF is 0.000208783
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| MMUT | protein_coding | protein_coding | ENST00000274813 | 12 | 32832 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125570 | 0 | 178 | 125748 | 0.000708 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.229 | 401 | 414 | 0.968 | 0.0000212 | 4896 |
| Missense in Polyphen | 169 | 194.83 | 0.8674 | 2234 | ||
| Synonymous | 0.0118 | 132 | 132 | 0.999 | 0.00000628 | 1484 |
| Loss of Function | 0.402 | 35 | 37.7 | 0.929 | 0.00000228 | 415 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00210 | 0.00210 |
| Ashkenazi Jewish | 0.00149 | 0.00149 |
| East Asian | 0.00136 | 0.00136 |
| Finnish | 0.0000466 | 0.0000462 |
| European (Non-Finnish) | 0.000476 | 0.000440 |
| Middle Eastern | 0.00136 | 0.00136 |
| South Asian | 0.00108 | 0.00108 |
| Other | 0.000652 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the degradation of several amino acids, odd- chain fatty acids and cholesterol via propionyl-CoA to the tricarboxylic acid cycle. MCM has different functions in other species.;
- Disease
- DISEASE: Methylmalonic aciduria type mut (MMAM) [MIM:251000]: An often fatal disorder of organic acid metabolism. Common clinical features include lethargy, vomiting, failure to thrive, hypotonia, neurological deficit and early death. Two forms of the disease are distinguished by the presence (mut-) or absence (mut0) of residual enzyme activity. Mut0 patients have more severe neurological manifestations of the disease than do MUT- patients. MMAM is unresponsive to vitamin B12 therapy. {ECO:0000269|PubMed:10923046, ECO:0000269|PubMed:11350191, ECO:0000269|PubMed:1346616, ECO:0000269|PubMed:1351030, ECO:0000269|PubMed:15643616, ECO:0000269|PubMed:15781192, ECO:0000269|PubMed:16281286, ECO:0000269|PubMed:1670635, ECO:0000269|PubMed:17113806, ECO:0000269|PubMed:17957493, ECO:0000269|PubMed:19588269, ECO:0000269|PubMed:1977311, ECO:0000269|PubMed:1980486, ECO:0000269|PubMed:22727635, ECO:0000269|PubMed:25125334, ECO:0000269|PubMed:26615597, ECO:0000269|PubMed:27167370, ECO:0000269|PubMed:28101778, ECO:0000269|PubMed:7909321, ECO:0000269|PubMed:7912889, ECO:0000269|PubMed:9285782, ECO:0000269|PubMed:9452100, ECO:0000269|PubMed:9554742}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.691
Intolerance Scores
- loftool
- rvis_EVS
- 0.2
- rvis_percentile_EVS
- 67.36
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score